DNA X Completes Major Business Pivot, Sells Mobile Assets for $15M, Shifts to Crypto Trading

summarizeSummary

DNA X, Inc. announced its Q4/FY2025 results alongside a complete business transformation, selling its mobile device assets for $15 million and fully pivoting to cryptocurrency trading.

check_boxKey Events

• Complete Business Transformation

  DNA X, Inc. has fully transitioned from mobile device manufacturing to operating a cryptocurrency trading platform, following the acquisition of the DNA X platform in December 2025 and a rebranding in January 2026.

• Significant Asset Sale

  The company completed the sale of its mobile device design and manufacturing business for $15 million in January 2026. $13.5 million was paid immediately, with the remainder due in nine months. Proceeds were used to repay debt and support the new crypto trading business.

• Q4 and Full Year 2025 Financial Results

  The company reported a net loss from continuing operations of $(7.96) million for 2025 and a total net loss of $(20.66) million. Cash and cash equivalents stood at $1.30 million as of December 31, 2025, prior to the asset sale proceeds.

• Leadership Changes

  The CEO and a board member resigned in January 2026, with the Executive Chairman becoming acting CEO. A new board member, Scott Walker, a co-founder of DNA Holdings, was appointed.

auto_awesomeAnalysis

This filing announces DNA X, Inc.'s financial results for Q4 and full year 2025, but more importantly, details a complete business transformation. The company has successfully pivoted from its mobile device manufacturing business to focus entirely on cryptocurrency trading. This strategic shift involved the acquisition of the DNA X cryptocurrency trading platform in December 2025 and the subsequent sale of its mobile device assets for $15 million in January 2026. The proceeds from this significant asset disposition, which is approximately three times the company's current market capitalization, were used to repay debt and fund the new crypto trading operations. This marks a fundamental change in the company's business model and future prospects, providing critical capital for its new direction despite ongoing losses from continuing operations. The market will now re-evaluate DNA X as a cryptocurrency trading platform provider.